Cited by

• Using membrane perturbing small molecules to target chronic persistent infections.

  Schrank CL, Wilt IK, Monteagudo Ortiz C, Haney BA, Wuest WM. Schrank CL, et al. RSC Med Chem. 2021 Jun 11;12(8):1312-1324. doi: 10.1039/d1md00151e. eCollection 2021 Aug 18. RSC Med Chem. 2021. PMID: 34458737 Free PMC article. Review.
• Drug Repurposing: In vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium.

  She P, Wang Y, Li Y, Zhou L, Li S, Zeng X, Liu Y, Xu L, Wu Y. She P, et al. Front Microbiol. 2021 May 6;12:579806. doi: 10.3389/fmicb.2021.579806. eCollection 2021. Front Microbiol. 2021. PMID: 34025592 Free PMC article.
• The potential target of bithionol against Staphylococcus aureus: design, synthesis and application of biotinylated probes Bio-A2.

  Luo Y, Wen Z, Xiong Y, Chen X, Shen Z, Li P, Peng Y, Deng Q, Yu Z, Zheng J, Han S. Luo Y, et al. J Antibiot (Tokyo). 2023 Jul;76(7):406-415. doi: 10.1038/s41429-023-00618-x. Epub 2023 Apr 25. J Antibiot (Tokyo). 2023. PMID: 37185582
• The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.

  Smith CO, Nehrke K, Brookes PS. Smith CO, et al. Biochem J. 2017 Jun 9;474(12):2067-2094. doi: 10.1042/BCJ20160623. Biochem J. 2017. PMID: 28600454 Free PMC article. Review.
• A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus.

  Kim W, Zou G, Hari TPA, Wilt IK, Zhu W, Galle N, Faizi HA, Hendricks GL, Tori K, Pan W, Huang X, Steele AD, Csatary EE, Dekarske MM, Rosen JL, Ribeiro NQ, Lee K, Port J, Fuchs BB, Vlahovska PM, Wuest WM, Gao H, Ausubel FM, Mylonakis E. Kim W, et al. Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16529-16534. doi: 10.1073/pnas.1904700116. Epub 2019 Jul 29. Proc Natl Acad Sci U S A. 2019. PMID: 31358625 Free PMC article.